GlassScriptPhysician profile
Stephen Daniel Sasser
NPI 1841581600
$1,173.58
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $313 · 2020: $14.44 · 2021: $22.77 · 2022: $359 · 2023: $377 · 2024: $88.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $465.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $201.43 | 2020-2023 | Wegovy, Ozempic |
| Takeda Pharmaceuticals U.S.A., INC. | $192.24 | 2019-2023 | Trintellix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.33 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $88.46 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $79.70 | 2022-2024 | Breztri, Farxiga |
| Pfizer INC. | $64.76 | 2019-2023 | |
| Dexcom, INC. | $54.23 | 2022-2023 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $53.56 | 2023 | Cologuard Collection Kit |
| Amgen INC. | $52.23 | 2019-2024 | Otezla, Repatha |
| Abbott Laboratories | $42.44 | 2019-2024 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $40.55 | 2022-2023 | Shingrix, Trelegy Ellipta |
| Bayer Healthcare Pharmaceuticals INC. | $34.59 | 2022-2023 | |
| Smith+Nephew, INC. | $26.70 | 2022 | |
| Grifols USA, LLC | $24.74 | 2023 | Prolastin-C Liquid |
| Roche Diagnostics Corporation | $23.10 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nabriva Therapeutics, Plc | $20.02 | 2022 | |
| Shield Therapeutics INC | $13.94 | 2023 | Accrufer |
| Lilly USA, LLC | $13.79 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $12.51 | 2021 | |
| Organon LLC | $10.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Sasser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.